Literature DB >> 24820749

Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.

T Lhermusier1, S Voisin2, G Murat3, S Mejean3, C Garcia4, V Bataille3, M J Lipinski5, D Carrié3, P Sié4.   

Abstract

Entities:  

Keywords:  Acute coronary syndrome; Clopidogrel; Platelet reactivity; Prasugrel; Ticagrelor

Mesh：

Substances：

Year:  2014        PMID： 24820749     DOI： 10.1016/j.ijcard.2014.04.208

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  Switching P2Y12-receptor inhibitors in patients with coronary artery disease.

Authors:  Fabiana Rollini; Francesco Franchi; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2015-08-18       Impact factor: 32.419

Review 2.  The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: A systematic review and meta-analysis.

Authors:  Qiutong Tan; Xin Jiang; Sichao Huang; Tiantian Zhang; Lin Chen; Siwen Xie; Enpan Mo; Jun Xu; Shaohui Cai
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

3.  Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis.

Authors:  Lulu Dai; Jiawei Xu; Yuerong Jiang; Keji Chen
Journal:  Front Cardiovasc Med       Date:  2022-06-09

4.  Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis.

Authors:  Mingxiang Wen; Yaqi Li; Xiang Qu; Yanyan Zhu; Lingfang Tian; Zhongqin Shen; Xiulin Yang; Xianqing Shi
Journal:  BMC Cardiovasc Disord       Date:  2020-10-01       Impact factor: 2.298
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.